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Abstract
Background: In Trinidad and the wider Caribbean, subtype B Human Immunodeficiency Virus-type 1 (HIV-1B)
overwhelmingly accounts for HIV infection among heterosexuals; this contrasts with the association of HIV-1B with
homosexual transmission and injecting drug use globally. The HIV envelope contains genetic determinants of cell tropism
and evasion from immune attack. In this study we investigate the genetic properties of the env V1-C4 of HIV-1B soon after
transmission to Trinidadian heterosexuals. This will reveal distinctive genetic features of the strains that cause the HIV-1B
epidemic in Trinidad and generate insights to better understand their properties.
Methodology/Principal Findings: Quasispecies sampling was performed on the env V1-C4 of HIV-1B strains soon after
transmission to heterosexual Trinidadians in a cohort of seroconverters. Phylogenetic relationships were determined for
these quasispecies and the length and number of asparagine (N) linked glycosylation sites (NLGS) in their variable loops
compared to that for HIV-1B globally. Signature amino acids within the constant domains of the env V1-C4 were identified
for heterosexually transmitted HIV-1B from Trinidad relative to HIV-1B globally. HIV-1B obtained from Trinidadian
heterosexuals soon after seroconversion had significantly longer V2 loops with one more glycosylation site, shorter V3 loops
and no significant difference in V1 or V4 when compared to HIV-1B obtained soon after seroconversion from infected
individuals in the rest of the world. HIV-1B soon after seroconversion and during chronic infection of Trinidadians was not
significantly different, suggesting that distinctly long V2 loops are characteristic of HIV-1B in Trinidad. A threonine deletion
at position 319 (T319-) along with the substitutions R315K and S440R were found to be distinctly associated with HIV-1B
from Trinidad compared to HIV-1B globally.
Conclusions: This finding of distinctive genetic features that are characteristic of HIV-1B strains from Trinidad is consistent
with the Trinidad epidemic being established by a founder strain or closely related founder strains of HIV-1B.
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Introduction
Subtype B Human Immunodeficiency Virus-type 1 (HIV-1B) is
typically associated with HIV epidemics among men who have sex
with men (MSM) and injecting drug users worldwide, but in the
Caribbean, HIV-1B is responsible for the heterosexual HIV-1
epidemic [1,2]. The introduction of HIV-1 into Trinidad is
proposed to have been via homosexual contact with North
American men [3] and the virus later introgressed into the
heterosexual population via a bisexual bridge [4]. During the mid
1980s to early 1990s, the HIV-1 epidemic in Trinidad expanded
explosively within the heterosexual population and this epidemic
was caused by closely related phylogenetic strains of HIV-1B [4].
The gp120 env of HIV-1 is essential for virus transmission, entry
into host cells and immune escape. Env gp120 is the most variable
region of the HIV-1 genome and has five constant (C1–C5)
domains interspersed with five variable domains (V1–V5).
Variability within env produces different phenotypes of HIV-1
cellular tropism and resistance to immune assault [5,6]. Here we
report molecular features within env V1–V4 that are distinctly
associated with heterosexually transmitted HIV-1B from Trinidad.
These results may also have implications for disease progression in
individuals who acquire HIV-1B that is circulating in Trinidad
and may be informative for the development of strategies to block
HIV transmission.
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Subjects
Peripheral blood mononuclear cells (PBMCs) were obtained
from 19 Trinidadian heterosexuals within 2 months of serocon-
version and 8 Argentinian MSM within 3 months of seroconver-
sion. For 5 of the 19 HIV infected Trinidadians, PBMCs were also
collected 1–2 years post infection and used as a source of viral
sequences from chronic infection . Blood from HIV-infected
Trinidadians were collected between 1993 and 2000 as described
elsewhere [4] and PBMCs stored at a repository at Duke
University Medical Centre. The demographic features of the
Trinidadians were previously described [4]. PBMCs from
Argentinians were collected under a study of HIV-1 incidence
among a Buenos Aires cohort of MSM [7]. Institutional review
boards approved both studies and each subject gave informed
written consent.
Amplification and Sequencing
DNA was extracted from PBMCs using the QiAmp DNA
extraction kit (QIAgen, Valencia, CA, USA) and subjected to
single genome amplification (SGA) [8], in which the template was
end point diluted until no more than 40% of PCR replicates
produced amplicons. The env V1-C4 region of HIV proviral DNA
was amplified and sequenced on the Applied Biosystems 3130xl
automated sequencer using Big Dye terminators (Applied
Biosystems) and sequences assembled using Sequencher v4.6
(GeneCodes Corporation, Ann Arbor, MI).
Sequence Analysis
Sequences were screened for laboratory contamination using
HIV BLAST. Hypermutants were detected using HYPERMUT
v2.0 (http://www.hiv.lanl.gov/content/sequence/HYPERMUT/
hypermut.html) [9] and excluded from further analyses. All
sequences were trimmed to the env V1-C4 (nts 6584–7601 relative
to HXB2) region. CLUSTAL W was used for multiple sequence
alignments and the alignments manually refined. Neighbour-
joining phylogenetic trees were constructed and nucleotide
diversity among quasispecies from each patient visualized using
HIGHLIGHTER (http://www.hiv.lanl.gov/content/sequence/
HIGHLIGHT/highlighter.html). Recombinants were detected
using the Recombination Identification Program 3.0 (http://
www.hiv.lanl.gov/content/sequence/RIP/RIP.html) and intrapa-
tient quasispecies diversity computed using maximum composite
Table 1. Features of subtype B HIV-1 quasispecies isolated from Argentinian men who have sex with men and Trinidadian
heterosexuals recently following seroconversion.
Country Risk Factor
Patient/
Sample ID DPS
Number of Single
Genomes
Number of Founder
Virus(es) Recombinants
Argentina MSM AR145447 90 11 1 No
Argentina MSM AR151263 90 20 1 No
Argentina MSM AR101815 75 5 2 No
Argentina MSM AR134742 90 14 1 No
Argentina MSM AR137681 90 20 1 No
Argentina MSM AR138910 60 20 1 No
Argentina MSM AR142467 90 11 1 No
Argentina MSM AR159687 90 10 1 No
Trinidad Heterosexual SC05.QH0020 10 19 1 No
Trinidad Heterosexual SC11.QH0053 37 7 1 No
Trinidad Heterosexual SC20.QH0121 26 20 1 No
Trinidad Heterosexual SC22.QH0126 35 15 1 No
Trinidad Heterosexual SC24.QH0532 34 20 1 No
Trinidad Heterosexual SC25.QH0535 59 20 1 No
Trinidad Heterosexual SC31.QH0605 25 20 1 No
Trinidad Heterosexual SC33.QH0704 43 20 2 Yes
Trinidad Heterosexual SC34.QH0705 6 12 1 No
Trinidad Heterosexual SC35.QH0712 34 20 1 No
Trinidad Heterosexual SC41.QH0776 40 20 1 No
Trinidad Heterosexual SC42.QH0791 7 20 $2Y e s
Trinidad Heterosexual SC45.QH0865 46 20 1 No
Trinidad Heterosexual SC47.QH0944 30 20 2 Yes
Trinidad Heterosexual TT27.DUK42010 5 20 2 No
Trinidad Heterosexual TT28.DUK42011 3 20 1 No
Trinidad Heterosexual TT31.DUK42043 5 20 1 No
Trinidad Heterosexual TT34.DUK42067 13 13 1 No
Trinidad Heterosexual TT37.DUK42118 0 8 3 No
DPS=days post seroconversion.
doi:10.1371/journal.pone.0019995.t001
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in each sequence and correspond to amino acids 131–156, 157–
196, 296–331 and 385–418, respectively, of the HXB2 envelope.
Potential N-linked glycosylation sites (NLGS) were identified using
N-GLYCOSITE (http://www.hiv.lanl.gov/content/sequence/
GLYCOSITE/glycosite.html) [10] and genotypic coreceptor
analysis of V3 executed using WEBPSSM (http://fortinbras.us/
cgi-bin/fssm/fssm.pl) [11]. Mann–Whitney Rank Sum tests were
used for comparison between groups. VESPA (http://www.hiv.
lanl.gov/content/sequence/VESPA/vespa.html) was used to
identify signature amino acids within C2–C3 and C4 (amino
acids 197–384 and 419–459 respectively, relative to the HXB2
envelope) of recently transmitted HIV-1B from Argentina and
Trinidad. Fishers exact test was used to establish whether the
signature amino acids identified by VESPA were significantly
associated with each group. All reported p-values are 2 sided.
Nucleotide sequence accession numbers
Sequences generated in this study were deposited in Genbank
under accession numbers HM126017-HM126454. Numerous
HIV-1 subtype B sequences from the GenBank database were
used for comparative analyses in this study. The GenBank
accession numbers for the database sequences used are stated
below. Database sequences of HIV-1 from Argentinian men who
have sex with men (DQ383750, DQ383752 [16]), database
sequences of HIV-1 from heterosexuals (AJ417429-AJ417431
[17]; AY308760-AY308762 [18]; AY535447-AY535454 [19];
AY835447, AY835449 [20]; DQ821488 [21]; EF593236,
EF593237, EF593280, EF593282; EU588776- EU588785 [22];
EU577388-EU577403, EU576706-EU576726, EU577404-EU-
577424, EU577447-EU577461, EU577479-EU577509, EU57-
7604-EU577628, EU577645-EU577674, EU576728-EU576757
[15]; FJ496167-FJ496172, FJ496174- FJ496184 [23]), database
sequences of HIV-1 from men who have sex with men (AJ007943-
AJ007945; DQ853427-DQ853435 [24]; EU184091-EU184096,
EU184101-EU184206, EU184208-EU184217, EU184219-EU-
184227, EU184230-EU184241, EU184243-EU184241, EU184-
243-EU184244, EU184246-EU184279, EU184289-EU184291,
EU184293-EU184296, EU184298-EU184413, EU184415-EU-
184434, EU184437-EU184451, EU184453-EU184456, EU184-
458-EU184465, EU184474-EU184490, EU184492, EU184501-
EU184538, EU184540-EU184571, EU184573-EU184597, EU1-
Figure 1. Neighbour-joining phylogeny of HIV-1 quasispecies based on env V1–V4. (A) Phylogeny of quasispecies isolated from
Argentinean MSM and (B) Phylogeny of quasispecies isolated from Trinidadian heterosexuals. The sequences were isolated from samples collected
soon after seroconversion. Percentage intrapatient diversity is presented for each patient and * highlights the patient who is infected by distantly
related strains.
doi:10.1371/journal.pone.0019995.g001
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doi:10.1371/journal.pone.0019995.g002
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588762, EU588833-EU588841, EU588857-EU588869, EU5-
88897-EU588897 [22]; EU576274, EU576276-EU576292, EU-
576294-EU576302, EU576303-EU576321, EU576323-EU576-
342, EU576396-EU576424; EU576471-EU576500, EU5765-
02-EU576553, EU577039-EU577045, EU577047-EU577060,
EU577062-EU577100, EU577102-EU577118, EU577344-EU57-
7350, EU577352-EU577364, EU577366-EU577379, EU577381-
EU577387, EU577425-EU577446, EU577510-EU577552, EU-
577554-EU577588, EU577675-EU577691, EU577741-EU5777-
61 [15]; FJ496081-FJ496085 [23]), database sequences of pre-
valent Trinidadian HIV-1 (EU839606, EU839609-10 and
HM162890-HM162896 [2]) and database sequences of HIV-1
from Haiti (EU839600-EU839604 [2], U08441, U08443-U08447
[26]).
Results
Phylogenetic analysis confirmed that all sequences obtained
were subtype B and they were all predicted to use the CCR5
coreceptor based on V3 analysis. HIGHLIGHTER and phyloge-
netic analysis of the quasispecies isolated indicate that a single
founder variant infected 7 of the 8 Argentinians and 14 of the 19
Trinidadians, while the remaining patients were infected by two or
more founder variants. Recombinant quasispecies were detected
in 3 of the 5 Trinidadians who were infected by 2 or more founder
variants (Table 1). The sequences from each recent seroconverter
formed distinct clusters with strong bootstrap suppport (.95%)
with the exception of one Argentinian patient (AR101815). The
sequences from AR101815 formed two non-neighbouring clusters
on the phylogenetic tree (Figure 1), suggesting that patient
AR101815 was infected by two distantly related strains. Intrapa-
tient nucleotide diversity ranged from 0.06%–9.4% (0.06%–
0.48%, if AR101815 is excluded) for the recent Argentinian
seroconverters and 0.04%–1.13% for the recent Trinidadian
seroconverters. A phylogenetic tree was constructed using the env
V1-C4 sequences of HIV-1B from 46 Trinidadians (19 from this
study and 27 sequences from the Los Alamos Database) along with
randomly choosen HIV-1B sequences from other Caribbean
territories and the rest of the world. Only one representative
sequence from each of the 46 Trinidadians was included in the
analysis and represents all available env V1-C4 sequences from
HIV-1B infected Trinidadian heterosexuals. With the exception of
a cluster that contained 13 Trinidad HIV-1B strains and had 98%
bootstrap support, the phylogenetic tree generated showed no
Figure 3. Multiple alignment of env V2. All available (n=46) V2 loop sequences from subtype B HIV-1 from Trinidad are present in
the alignment.
doi:10.1371/journal.pone.0019995.g003
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viruses consists of 10 acute sequences and 3 prevalent sequences.
Of the ten acute viruses 7 were previously reported to form a
subcluster within Trinidad viruses [4].
The length and number of NLGS within the contiguous V1–V4
and the individual variable loops were compared between HIV-1B
obtained from Trinidadian heterosexuals soon after seroconver-
sion, HIV-1B obtained from Argentinian MSM soon after
seroconversion and database HIV-1B sequences obtained from
MSM and heterosexuals by SGA within 3 months of seroconver-
sion. The only difference observed between the groups of HIV-1B
compared, was that the V2 loops of HIV-1B obtained from
Trinidadian heterosexuals soon after seroconversion were signif-
icantly longer, with one more glycosylation site (Figure 3), and
their V3 loops significantly shorter compared to all other HIV-1B
(Table 2). There was no significant difference in the variable loops
betweenHIV-1B obtained soon after seroconversion and during
chronic infection from 9 Trinidadian heterosexuals or between
HIV-1 obtained from Trinidadian heterosexuals soon after
seroconversion and HIV-1B from a prevalence study conducted
in 2000–2003 in Trinidad [2]. HIV-1B from Trinidad also had
significantly longer V2 and shorter V3 than HIV-1B from Haiti
(Table 2), which is believed to have the oldest HIV epidemic in the
Western Hemisphere [12].
Twelveamino acid positions inV1-V4 were identified byVESPA
as differentiating HIV-1B that were obtained from Trinidadian
heterosexuals and Argentinian MSM soon after seroconversion,
however biological data is available for only three of these positions
R315K, S440R and T319-. R315K and T319A (T319- was
observed for the Trinidadians) in conjunction with an additional
NLGS confers escape from neutralization by the anti-V3 mono-
clonal antibody KD-247 [13], whilst S440R is associated with
resistance against candidate HIV-1 fusion inhibitor BMS378806
[14]. R315K and T319- are present in 42% and 74% of HIV-1B
obtained from Trinidadian heterosexuals soon after seroconversion
respectively, but are absent from HIV-1B obtained from Argenti-
nian MSM soon after seroconversion and are present in ,18% of
HIV-1B database sequences obtained from heterosexual or MSM
soon after seroconversion in the rest of the world. S440R is present
in 90% of HIV-1B obtained from Trinidadian heterosexuals soon
after seroconversion, but in ,40% of HIV-1B obtained from
Argentinian MSM soon after seroconversion and ,60% of
database sequences obtained from heterosexual or MSM soon after
seroconversion in the rest of the world.
Discussion
In this study we investigated genetic features of the env V1-C4 of
heterosexually transmitted HIV-1B from Trinidad, to unveil
whether distinct genetic features are associated with HIV-1B
strains in this heterosexual epidemic and garner insights to
improve our understanding of these HIV-1B strains. The majority
of patients were infected by a single strain (88% Argentinians and
74% Trinidadians) and this is consistent with a low number of
viruses establishing infection in sexual HIV-1 transmission [8,15] .
Half of the 20 HIV-1B infected MSM studied by Keele et al were
infected by more than one virus strains [15] however we found
multiple infecting virus strains in only 12% (1/8) Argentinian
MSM. Compared to the study by Keele et al, we studied a smaller
number of MSM and sampled fewer virus isolates from each
patient. It is unclear whether our finding that a higher percentage
of Argentinian MSM was infected by a single strain compared to
MSM in other studies is due to our sampling limitations or natural
variation between populations.
This study defines genetic features in the V1-C4 region of env
that distinguishes heterosexually transmitted HIV-1B in Trinidad
from HIV-1B transmitted globally and is consistent with the
previous suggestion that the HIV epidemic in Trinidad likely
resulted from a single introduction of HIV-1 [4]. Longer, more
glycosylated V2 loops, shorter V3 loops (due to T319- deletion)
Table 2. Comparison of the median length and number of N-Linked Glycosylation Sites in the Env V2 and V3 of Subtype B HIV-1
from Trinidad and the Rest of the World (p-values represent comparison between recently transmitted HIV-1 from Trinidadian
heterosexuals and others).
V2 V3
Length/aa Number NLGS Length/aa Number NLGS
Recently Transmitted HIV-1 from Trinidadian Heterosexuals,
n=19
46 3 34
Due to T319_
1
VS
Recently Transmitted HIV-1 from Argentinian MSM, n=10* 39
P,0.001
2
P,0.01
35
P,0.001
1
ns
Recently Transmitted HIV-1 from Database MSM, n=62 39
P,0.001
2
P,0.001
35
P,0.001
1
ns
Recently Transmitted HIV-1 from Database Heterosexuals,
n=11
39
P,0.01
2
P,0.01
35
P,0.01
1
ns
Chronic HIV-1 from Trinidadian Heterosexuals, n=9 46
ns
3
ns
34
ns
1
ns
Prevalent HIV-1 from Trinidad**,
n=10
46
ns
3
ns
34
ns
1
ns
HIV-1 from Haiti, n=11 43
P,0.05
2
ns
35
P,0.05
1
ns
ns= not significant,
*bulk database sequences for two Argentinians within 3 months of seroconversion were included in the analyses,
**bulk database sequences [2].
doi:10.1371/journal.pone.0019995.t002
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heterosexually transmitted HIV-1B from Trinidad. These signa-
tures correlate with neutralization resistance mutations developed
by prototype laboratory strains in different in vitro studies [6,13,15].
Further studies to assay the neutralization activity of these virus
strains must therefore be done as this has implications for disease
progression and the transmission of HIV-1 among Trinidadians.
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